The Role of Apoptosis in Cancer Development and Treatment: Focusing on the Development and Treatment of Hematologic Malignancies

被引:37
作者
Zivny, J. [1 ,2 ]
Klener, P., Jr. [1 ,2 ,3 ,4 ]
Pytlik, R. [3 ,4 ]
Andera, L. [5 ]
机构
[1] Charles Univ Prague, Inst Pathol Physiol, Fac Med 1, Prague 12853 2, Czech Republic
[2] Charles Univ Prague, Ctr Expt Hematol, Fac Med 1, Prague 12853 2, Czech Republic
[3] Charles Univ Prague, Dept Med 1, Dept Clin Haematol, Fac Med 1, Prague 12853 2, Czech Republic
[4] Charles Univ Prague, Gen Teaching Hosp, Prague 12853 2, Czech Republic
[5] Czech Acad Sci, Inst Mol Genet, Lab Cell Signaling & Apoptosis, Prague, Czech Republic
关键词
Cancer; leukemia; lymphoma; apoptosis; hematology; TUMOR-NECROSIS-FACTOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; PROTEIN-KINASE-C; ACUTE MYELOID-LEUKEMIA; BCL-2 ANTISENSE OLIGONUCLEOTIDE; NF-KAPPA-B; HISTONE DEACETYLASE INHIBITOR; ENDOPLASMIC-RETICULUM CA2+; SUBEROYLANILIDE HYDROXAMIC ACID; FARNESYL TRANSFERASE INHIBITOR;
D O I
10.2174/138161210789941883
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Apoptosis is a normal aspect of human physiology ensuring tissue homeostasis. Evasion of endogenous cell death processes, including apoptosis, represents one of the characteristics of cancer. Defects in the physiological mechanisms of apoptosis contribute to the pathological cell expansion and to the development and progression of cancer. Resistance of malignant cells to cancer therapeutic agents may be, in some cases, caused by dysregulation of apoptotic pathways, e. g. BCL2 or IAP overexpression. The understanding of the physiological mechanisms that control apoptosis and the elucidation of apoptotic defects in cancer cells may lead to the development of targeted cancer therapies. Apoptotic pathways, molecules involved in the cross-talk between individual apoptosis pathways and promising new anti-cancer agents, which trigger directly or indirectly apoptosis of hematologic cancer cells, are reviewed in this article.
引用
收藏
页码:11 / 33
页数:23
相关论文
共 356 条
[71]   Antisense strategy shows that Mcl-1 rather than Bcl-2 or BCI-xL is an essential survival protein of human myeloma cells [J].
Derenne, S ;
Monia, B ;
Dean, NM ;
Taylor, JK ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R ;
Amiot, M .
BLOOD, 2002, 100 (01) :194-199
[72]  
DERVEEN AH, 2000, ANTICANCER RES, V20, P3467
[73]   Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation [J].
Deschesnes, RG ;
Huot, J ;
Valerie, K ;
Landry, J .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (06) :1569-1582
[74]   IAP family proteins - suppressors of apoptosis [J].
Deveraux, QL ;
Reed, TC .
GENES & DEVELOPMENT, 1999, 13 (03) :239-252
[75]  
DISPENZIERI A, 2006, HAEMATOLOGICA
[76]  
DREXLER HG, 1989, BLOOD, V74, P1747
[77]   Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J].
Du, CY ;
Fang, M ;
Li, YC ;
Li, L ;
Wang, XD .
CELL, 2000, 102 (01) :33-42
[78]   Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death [J].
Dutton, A ;
O'Neil, JD ;
Milner, AE ;
Reynolds, GM ;
Starczynski, J ;
Crocker, J ;
Young, LS ;
Murray, PG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (17) :6611-6616
[79]   Mammalian caspases: Structure, activation, substrates, and functions during apoptosis [J].
Earnshaw, WC ;
Martins, LM ;
Kaufmann, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :383-424
[80]   Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL [J].
Emery, JG ;
McDonnell, P ;
Burke, MB ;
Deen, KC ;
Lyn, S ;
Silverman, C ;
Dul, E ;
Appelbaum, ER ;
Eichman, C ;
DiPrinzio, R ;
Dodds, RA ;
James, IE ;
Rosenberg, M ;
Lee, JC ;
Young, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14363-14367